133 related articles for article (PubMed ID: 28104572)
1. Progressive heart disease in mucopolysaccharidosis type I mice may be mediated by increased cathepsin B activity.
Baldo G; Tavares AM; Gonzalez E; Poletto E; Mayer FQ; Matte UD; Giugliani R
Cardiovasc Pathol; 2017; 27():45-50. PubMed ID: 28104572
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin B inhibition attenuates cardiovascular pathology in mucopolysaccharidosis I mice.
Gonzalez EA; Martins GR; Tavares AMV; Viegas M; Poletto E; Giugliani R; Matte U; Baldo G
Life Sci; 2018 Mar; 196():102-109. PubMed ID: 29366749
[TBL] [Abstract][Full Text] [Related]
3. Cardiac functional and histopathologic findings in humans and mice with mucopolysaccharidosis type I: implications for assessment of therapeutic interventions in hurler syndrome.
Braunlin E; Mackey-Bojack S; Panoskaltsis-Mortari A; Berry JM; McElmurry RT; Riddle M; Sun LY; Clarke LA; Tolar J; Blazar BR
Pediatr Res; 2006 Jan; 59(1):27-32. PubMed ID: 16326988
[TBL] [Abstract][Full Text] [Related]
4. Shotgun proteomics reveals possible mechanisms for cognitive impairment in Mucopolysaccharidosis I mice.
Baldo G; Lorenzini DM; Santos DS; Mayer FQ; Vitry S; Bigou S; Heard JM; Matte U; Giugliani R
Mol Genet Metab; 2015 Feb; 114(2):138-45. PubMed ID: 25541102
[TBL] [Abstract][Full Text] [Related]
5. Cardiac pathology in mucopolysaccharidosis I mice: Losartan modifies ERK1/2 activation during cardiac remodeling.
Gonzalez EA; Tobar Leitão SA; Soares DDS; Tavares AMV; Giugliani R; Baldo G; Matte U
J Inherit Metab Dis; 2021 May; 44(3):740-750. PubMed ID: 33145772
[TBL] [Abstract][Full Text] [Related]
6. Characterization of joint disease in mucopolysaccharidosis type I mice.
de Oliveira PG; Baldo G; Mayer FQ; Martinelli B; Meurer L; Giugliani R; Matte U; Xavier RM
Int J Exp Pathol; 2013 Oct; 94(5):305-11. PubMed ID: 23786352
[TBL] [Abstract][Full Text] [Related]
7. Evidence that glycosaminoglycan storage and collagen deposition in the cauda epididymidis does not impair sperm viability in the Mucopolysaccharidosis type I mouse model.
do Nascimento CC; Aguiar O; Viana GM; D Almeida V
Reprod Fertil Dev; 2020 Feb; 32(3):304-312. PubMed ID: 31679559
[TBL] [Abstract][Full Text] [Related]
8. Effects of enzyme replacement therapy started late in a murine model of mucopolysaccharidosis type I.
Pasqualim G; Baldo G; de Carvalho TG; Tavares AM; Giugliani R; Matte U
PLoS One; 2015; 10(2):e0117271. PubMed ID: 25646802
[TBL] [Abstract][Full Text] [Related]
9. Glycosaminoglycan-mediated loss of cathepsin K collagenolytic activity in MPS I contributes to osteoclast and growth plate abnormalities.
Wilson S; Hashamiyan S; Clarke L; Saftig P; Mort J; Dejica VM; Brömme D
Am J Pathol; 2009 Nov; 175(5):2053-62. PubMed ID: 19834056
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin B-associated Activation of Amyloidogenic Pathway in Murine Mucopolysaccharidosis Type I Brain Cortex.
Viana GM; Gonzalez EA; Alvarez MMP; Cavalheiro RP; do Nascimento CC; Baldo G; D'Almeida V; de Lima MA; Pshezhetsky AV; Nader HB
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093427
[TBL] [Abstract][Full Text] [Related]
11. Characterization of heart disease in mucopolysaccharidosis type II mice.
Tavares AMV; Gonzalez EA; Viana IS; Visioli F; Vera LNP; Baldo G
Cardiovasc Pathol; 2023; 67():107575. PubMed ID: 37730078
[TBL] [Abstract][Full Text] [Related]
12. Altered interaction and distribution of glycosaminoglycans and growth factors in mucopolysaccharidosis type I bone disease.
Kingma SDK; Wagemans T; IJlst L; Bronckers ALJJ; van Kuppevelt TH; Everts V; Wijburg FA; van Vlies N
Bone; 2016 Jul; 88():92-100. PubMed ID: 27105565
[TBL] [Abstract][Full Text] [Related]
13. Alterations of membrane lipids and in gene expression of ganglioside metabolism in different brain structures in a mouse model of mucopolysaccharidosis type I (MPS I).
Kreutz F; dos Santos Petry F; Camassola M; Schein V; Guma FC; Nardi NB; Trindade VM
Gene; 2013 Sep; 527(1):109-14. PubMed ID: 23774686
[TBL] [Abstract][Full Text] [Related]
14. Glycosaminoglycan fragments as a measure of disease burden in the mucopolysaccharidosis type I mouse.
Saville JT; McDermott BK; Fuller M
Mol Genet Metab; 2018 Feb; 123(2):112-117. PubMed ID: 29273385
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular aneurysm in an adult patient with mucopolysaccharidosis type I: comment on pathogenesis of a novel complication.
Cabrera GH; Fernández I; Dominguez M; Clarke LA
Mol Genet Metab; 2012 Aug; 106(4):470-3. PubMed ID: 22732207
[TBL] [Abstract][Full Text] [Related]
16. Evidence of a progressive motor dysfunction in Mucopolysaccharidosis type I mice.
Baldo G; Mayer FQ; Martinelli B; Dilda A; Meyer F; Ponder KP; Giugliani R; Matte U
Behav Brain Res; 2012 Jul; 233(1):169-75. PubMed ID: 22580166
[TBL] [Abstract][Full Text] [Related]
17. Morphologic description of male reproductive accessory glands in a mouse model of mucopolysaccharidosis type I (MPS I).
do Nascimento CC; Junior OA; D'Almeida V
J Mol Histol; 2020 Apr; 51(2):137-145. PubMed ID: 32162173
[TBL] [Abstract][Full Text] [Related]
18. Biomechanical and histological characterization of MPS I mice femurs.
Ferreira NY; do Nascimento CC; Pereira VG; de Oliveira F; Medalha CC; da Silva VC; D'Almeida V
Acta Histochem; 2021 Feb; 123(2):151678. PubMed ID: 33434858
[TBL] [Abstract][Full Text] [Related]
19. Morphological damage in Sertoli, myoid and interstitial cells in a mouse model of mucopolysaccharidosis type I (MPS I).
do Nascimento CC; Aguiar O; Viana GM; D'Almeida V
Mol Biol Rep; 2021 Jan; 48(1):363-370. PubMed ID: 33319323
[TBL] [Abstract][Full Text] [Related]
20. Progressive eye pathology in mucopolysaccharidosis type I mice and effects of enzyme replacement therapy.
Gonzalez EA; Visioli F; Pasqualim G; de Souza CFM; Marinho DR; Giugliani R; Matte U; Baldo G
Clin Exp Ophthalmol; 2020 Apr; 48(3):334-342. PubMed ID: 31925897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]